| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 01/05/1994 | EP0576623A1 Binding domains in notch and delta proteins |
| 01/05/1994 | EP0576609A1 Receptors for bombesin-like peptides |
| 01/05/1994 | EP0576590A1 Response element compositions and assays employing same |
| 01/05/1994 | EP0576589A1 Hydrazine containing conjugates of polypeptides and glycopolypeptides with polymers |
| 01/05/1994 | EP0576562A1 Lipid fractionation |
| 01/05/1994 | EP0576483A1 Biocidal proteins |
| 01/05/1994 | EP0576476A1 Immunoassay for detection of mutant p53 polypeptide in biological fluids |
| 01/05/1994 | EP0576471A1 Recombinant virus vectors encoding human papillomavirus proteins |
| 01/05/1994 | EP0576439A1 Monoclonal antibody against lps core |
| 01/05/1994 | EP0487615B1 Ferritin analogs |
| 01/05/1994 | EP0396733B1 Improved extraction methods for preparing thromboplastin reagents |
| 01/05/1994 | DE4221836A1 New mistletoe lectin - with immunomodulatory activity, useful for cancer adjuvant therapy |
| 01/05/1994 | DE4220759A1 DNA-Sequenzen für Oligosaccharid-Transporter, Plasmide, Bakterien und Pflanzen enthaltend einen Transporter sowie Verfahren zur Herstellung und Transformation von Hefestämmen zur Identifikation des Transporteers DNA sequences for oligosaccharide transporter, plasmids, bacteria and plants containing a van and processes for the production and transformation of yeast strains to identify the Transporteers |
| 01/05/1994 | CN1080188A Prevention of retinal injury and degeneration by specific factors |
| 01/04/1994 | US5276269 Lectin cDNA and transgenic plants derived therefrom |
| 01/04/1994 | US5276145 Methods and compositions; purified preparation of neural progenitor regulatory factor |
| 01/04/1994 | US5276142 Vaccines |
| 01/04/1994 | US5276141 Adding divalent metal ion to culture product to form a mixture which precipitates, harvesting said protein |
| 01/04/1994 | US5276138 Process for solubilizing animal hair |
| 01/04/1994 | US5276137 Enkephalin derivatives |
| 01/04/1994 | US5276136 Laminin A chain polypeptides from the amino terminal globular domain |
| 01/04/1994 | US5276017 In vitro fertilization and implantation |
| 01/04/1994 | US5276016 Alleviates aids symptoms |
| 01/04/1994 | US5276013 Conjugates of biologically stable polyfunctional molecules and polynucleotides for treating systemic lupus erythematosus |
| 01/04/1994 | US5275947 Non-A, non-B hepatitis virus antigen peptide |
| 01/04/1994 | US5275946 Thrombolytic agents with modified kringle domains |
| 01/04/1994 | US5275935 Amebic glycoconjugate and monoclonal antibody |
| 01/04/1994 | US5275934 Method of detecting viral infection in vaccinated animals |
| 01/04/1994 | US5275815 Bacillus thuringiensio NRRL B-18721 active against dipteran pests |
| 01/04/1994 | US5275813 Methods and compositions for vaccinating against feline immunodeficiency virus |
| 01/04/1994 | CA1325769C Sustained release protein compositions and method for making |
| 12/31/1993 | CA2099698A1 Peptide derivatives involved in cellular adhesion processes, process for their preparation and pharmaceutical compositions comprising thereof |
| 12/29/1993 | EP0576152A1 Protease and related DNA compounds |
| 12/29/1993 | EP0576095A1 Immunoassays with labeled thyronine hapten analogues |
| 12/29/1993 | EP0576092A1 Recombinant Feline herpesvirus vaccine |
| 12/29/1993 | EP0576050A1 Isolation and characterisation of the sfp gene of Bacillus subtilis |
| 12/29/1993 | EP0576049A1 A method of using eukaryotic expression vectors comprising the BK virus enhancer |
| 12/29/1993 | EP0575559A1 TGF-$g(b)1/$g(b)2: A NOVEL CHIMERIC TRANSFORMING GROWTH FACTOR-BETA |
| 12/29/1993 | EP0575557A1 Method of inhibiting padgem-mediated interactions using an inhibitor comprising a 2,6 sialic acid component |
| 12/29/1993 | EP0575555A1 Protein-induced morphogenesis |
| 12/29/1993 | EP0575553A1 Recombinant hybrid porin epitopes |
| 12/29/1993 | EP0575546A1 Prad1 cyclin and its cdna |
| 12/29/1993 | EP0575545A1 Pegylation of polypeptides |
| 12/29/1993 | EP0575544A1 Malaria recombinant poxvirus vaccine |
| 12/29/1993 | EP0575539A1 Means for in-vitro diagnosis of constituents of cytoplasmic granules and biological applications |
| 12/29/1993 | EP0575537A1 Soluble cd28 proteins and methods of treatment therewith |
| 12/29/1993 | EP0575528A1 Response element compositions and assays employing same |
| 12/29/1993 | EP0575522A1 Polypeptides derived from the human immunodeficiency virus endonuclease protein |
| 12/29/1993 | EP0575518A1 Methods and compositions for the selective inhibition of gene expression |
| 12/29/1993 | EP0575517A1 Lipid a analog/immunogenic carrier conjugates, the use thereof as vaccines and polyvalent hyperimmune gammaglobulins |
| 12/29/1993 | EP0575498A1 THE $i(TRK) TYROSINE KINASE RECEPTOR IS THE PHYSIOLOGICAL RECEPTOR FOR NERVE GROWTH FACTOR |
| 12/29/1993 | EP0575491A1 Genetically engineered vaccine strain |
| 12/29/1993 | EP0575490A1 GnRH ANALOGS |
| 12/29/1993 | EP0575485A1 Process for the development of binding mini-proteins |
| 12/29/1993 | EP0575464A1 Modified factor vii |
| 12/29/1993 | EP0575432A1 Modified proteins and their use for controlling viral infections |
| 12/29/1993 | EP0575357A1 Human follicle stimulating hormone receptor |
| 12/29/1993 | EP0575350A1 Method for culturing and transforming human stem cell-containing compositions |
| 12/29/1993 | EP0575348A1 FLAGELLA-LESS $i(BORRELIA) |
| 12/29/1993 | EP0575339A1 Analogs of acidic fibroblast growth factor having enhanced stability and biological activity |
| 12/29/1993 | EP0575319A1 Cloning and expression of renilla luciferase |
| 12/29/1993 | EP0575311A1 Control of secretion of milk |
| 12/29/1993 | EP0559729A4 Control of plant cell proliferation and growth |
| 12/29/1993 | EP0546091A4 Homologous recombination in mammalian cells |
| 12/29/1993 | EP0539573A4 Genomic modifications with homologous dna targeting |
| 12/29/1993 | EP0538398A4 Tissue-derived tumor growth inhibitors, methods for preparation and uses thereof |
| 12/29/1993 | EP0535038A4 Mammalian adipogenic factors |
| 12/29/1993 | EP0455682B1 Polypeptides having a human beta-adrenergic receptor activity, and playing a role in lipolytic response, nucleic acids coding for these polypeptides and use of said polypeptides for screening substances which act on these polypeptides |
| 12/29/1993 | EP0454739B1 Method of recovering purified epi protein from a solution especially a fermentation solution |
| 12/29/1993 | EP0375743B1 Monoclonal antibodies against human interleukin-4 and hybridomas producing the same |
| 12/29/1993 | EP0365597B1 Improved processes for the treatment of vascular disease |
| 12/29/1993 | EP0318562B1 Method of selectively inhibiting hiv |
| 12/29/1993 | EP0192671B1 Minactivin |
| 12/29/1993 | CN1079992A Neurotrophic factors having altered receptor binding specificities |
| 12/28/1993 | US5274087 cDNA coding for carcinoembryonic antigen (CEA) |
| 12/28/1993 | US5274081 Complex suitable for carrying out a method of purifying pre-S hepatitis B surface antigen |
| 12/28/1993 | US5274077 Protein or fragment thereof having a hormone or DNA binding domain of the recptor |
| 12/28/1993 | US5274076 N-alpha-acetyl,N-epsilon(histamine-succinyl-glycl)-L-lysyl-L -tyrosyl-N-epsilon(histamine-succinyl-glycyl)-L-lysylamide |
| 12/28/1993 | US5274075 Newly identified human epsilon immunoglobulin peptides and related products |
| 12/28/1993 | US5273982 An amidinoaryleneamidoalkylpiperazinyleneacetic acid |
| 12/28/1993 | US5273966 Having two mannose residues attached to the threonine (29) amino acid |
| 12/28/1993 | US5273962 Human urinary thrombomodulin with a modified glycosaminoglycan (GAG) binding site |
| 12/28/1993 | US5273901 Genetically engineered coccidiosis sporozoite 21.5 Kb antigen, ac-6b |
| 12/28/1993 | US5273896 Heme group attached to cysteine in a given specific sequence of 14 amino acids |
| 12/28/1993 | US5273889 Gamma-iterferon-leukotoxin gene fusions and uses thereof |
| 12/28/1993 | US5273884 Polypetides, antigens or vaccines protective against babesiosis |
| 12/28/1993 | US5273876 Comprising the genomic DNA of Towne strain human CMV, a foreign DNA insert and a promoter sequence |
| 12/28/1993 | US5273746 Bacillus thuringiensis isolates active against phthiraptera pests |
| 12/28/1993 | US5273744 A pure and antigenic polypeptide for cattle immunity |
| 12/28/1993 | CA1325695C Peptides with pharmaceutical activity |
| 12/28/1993 | CA1325612C Polypeptides and derivatives thereof as well as their use in pharmaceutical and diagnostic compositions |
| 12/28/1993 | CA1325611C Heliothis expression systems |
| 12/28/1993 | CA1325598C Cosmetic composition |
| 12/26/1993 | CA2099628A1 Anti-dcc gene product specific monoclonal antibody |
| 12/25/1993 | CA2099072A1 Kainate-binding, human cns receptors of the eaa4 family |
| 12/23/1993 | WO1993025713A1 Compositions and methods for detecting gene rearrangements and translocations |
| 12/23/1993 | WO1993025708A1 NUCLEOTIDIQUE SEQUENCES OBTAINED FROM GENES CODING PECTATE-LYASES, AND UTILIZATIONS THEREOF PARTICULARLY FOR THE DETECTION OF BACTERIA OF THE GENUS $i(ERWINIA) |
| 12/23/1993 | WO1993025700A1 Monoclonal antibodies to glycoprotein p |
| 12/23/1993 | WO1993025699A1 Vesicle membrane transport proteins |
| 12/23/1993 | WO1993025698A1 Vector particles resistant to inactivation by human serum |